Details
Category: Volume 07 Issue 03 March 2019
Hits: 1168

Title: Cyto-Pathological Diagnosis of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Tertiary Care Hospital, At Patna, Bihar

Authors: Dr Sunil Kumar, Dr C P Jaiswal, Dr Satyendu Sagar

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.120

Abstract

Objective: Post–kala-azar dermal leishmaniasis (PKDL) has potential for transmission of visceral leishmaniasis (VL) in endemic population which is dermatosis after cure of VL. It has importance for public health problem for elimination of visceral leishmaniasis (VL). The aim of present study was to evaluate the cyto-pathological diagnosis of post kala-azar dermal leishmaniasis.

Material and Methods: A total of 122 patients attending in Medical and Skin & VD OPD for different PKDL lesions were included in study.

Result: Out of 122 patients, 102 patients showed that median age of males and females at the time of diagnosis was significantly different (P = 0.013). A significant association was observed between family history of VL and sex of PKDL patients (c2 = 5.72, P < 0.01). 33% of the VL patient’s development PKDL within one year of treatment. The appearance of lesions and diagnosis is an important factor in VL transmission. There was a significant association between type of lesions and duration of appearance after VL treatment (c2 = 6.59, P = 0.001). Diagnosis of PKDL is still difficult in the field condition; however in tertiary care centres NMCH Patna demonstrated presence of LD bodies in macular lesion 39% and papulo-nodular 100%.

Conclusion: Majority of macular lesions were still undiagnosed even by advanced techniques which can hamper the national elimination programme for VL. India is a developing country and has high endemicity of VL particularly north Bihar, which contributes more than 80% of total VL and PKDL of India. Most sophisticated tests available today for the diagnosis of PKDL have their own challenges like lack of limited resources, lack of skills, lack of interpretations, lack of infra-structures; poorly contribute to diagnosis and delay the treatment among poor populations.

References

  1. Ramesh V, Mukherjee A, 1995. Post kala-azar dermal leishmaniasis. Int J Dermatol 34: 85–
  2. Zijlstra EE, El-Hassan AM, Ismail A, Ghalib HW, 1994. Endemic kala-azar in eastern Sudan: a longitudinal study on the inci-dence of clinical and sub-clinical infection and post kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51: 826–
  3. Beena K R , Ramesh V, Mukherjee A,: Identification of parasite antigen, correlation of parasite density and inflammation of skin lesion of post kala azar dermal leishmaniasis. J,Cutan Patholo 2003;30:616-20
  4. Zijlstra EE, Musa AM, Khalil EA, El-Hassan IM, El-Hassan AM, 2003. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 3: 87–
  5. Verma S, Bhandari V, Avishek K,Ramesh V, Salotra P.Reliable diagnosis of post kala-azar dermal leishmaniasis (PKDL) using slit aspirate specimen to avoid invasive sampling procdures .Trop Med Int health 2013;18:268-75.
  6. Sen Gupta PC, 1968. Leishmaniasisin India. J Med Assoc India 50: 34–
  7. Manson-Bahr PE, Bell DR, 1987. Manson’s Tropical Diseases. 19th edition. London: Bailliere Tindall/ELBS, 87–
  8. World Health Organization, 1984. The leishmaniases. Report of the WHO Expert Committee. World Health Organ Tech Rep Ser 701: 1–
  9. Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK, Sinha AK, 2008. Impact of amphotericin B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res 128: 38–
  10. Brahmachari UN, 1992. A new form of cutaneous leishmaniasis, dermal leishmanoid. Ind Med Gaz 57: 125–
  11. Dinesh DS, Kar SK, Kishore K, Palit A, Verma N, Gupta AK, Chauhan DS, Singh D, Sharma VD, Katoch VM, 2000. Screen-ing sandflies for natural infection with Leishmania donovani using a non-radioactive probe based on the total DNA of the parasite. Ann Trop Med Parasitol 94: 447–
  12. Salotra P, Singh R, 2006. Challenges in the diagnosis of post kala-azar dermal leishmaniasis. Indian J Med Res 123: 295–
  13. ICDDRB, 2007. Post kala-azar dermal leishmaniasis: new obser-vations challenge previous assumptions. Health Sci Bull 5: 6–
  14. Thakur CP, Kumar M, Mishra BN, Pandey AK, 1988. Rationali-zation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. BMJ 296: 1557–
  15. World Health Organization, 1990. Control of leishmaniasis. World Health Organ Tech Rep Ser 739: 1–
  16. Addy M, Nandi A, 1992. Ten years of kala-azar in West Bengal. Part I. Did post-kala-azar dermal leishmaniasis initiate the out-break in 24-Paraganas? Bull World Health Organ 70: 341–

Corresponding Author

Dr Sunil Kumar

Assistant Professor, Department of Pathology, Nalanda Medical College, Patna, Bihar, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.